【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 16
2 Introduction 17
2.1 Prosthetic Heart Valves Overview 17
3 Products under Development 18
3.1 Prosthetic Heart Valves – Pipeline Products by Stage of Development 18
3.2 Prosthetic Heart Valves – Pipeline Products by Segment 19
3.3 Prosthetic Heart Valves – Pipeline Products by Territory 20
3.4 Prosthetic Heart Valves – Pipeline Products by Regulatory Path 21
3.5 Prosthetic Heart Valves – Pipeline Products by Estimated Approval Date 22
3.6 Prosthetic Heart Valves – Ongoing Clinical Trials 23
4 Prosthetic Heart Valves – Pipeline Products under Development by Companies 24
4.1 Prosthetic Heart Valves Companies – Pipeline Products by Stage of Development 24
4.2 Prosthetic Heart Valves – Pipeline Products by Stage of Development 27
5 Prosthetic Heart Valves Companies and Product Overview 31
5.1 Aegis Surgical Limited Company Overview 31
5.1.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 AorTech International plc Company Overview 32
5.2.1 AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview 32
5.3 Apica Cardiovascular Limited Company Overview 34
5.3.1 Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Boston Children’s Hospital Company Overview 35
5.4.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 35
5.5 Boston Scientific Corporation Company Overview 37
5.5.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Braile Biomedica Ltda. Company Overview 46
5.6.1 Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 Caisson Interventional, LLC Company Overview 48
5.7.1 Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Cardiac Dimensions, Inc. Company Overview 49
5.8.1 Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.9 CardiAQ Valve Technologies, Inc. Company Overview 53
5.9.1 CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.10 Cardio3 BioSciences SA Company Overview 59
5.10.1 Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview 59
5.11 Cephea Valve Technologies, Inc. Company Overview 60
5.11.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 Clemson University Company Overview 61
5.12.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Colibri Heart Valve, LLC Company Overview 62
5.13.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 CorMatrix Cardiovascular, Inc. Company Overview 70
5.14.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.15 CryoLife, Inc. Company Overview 75
5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.16 Cytograft Tissue Engineering, Inc. Company Overview 77
5.16.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.17 Direct Flow Medical, Inc. Company Overview 78
5.17.1 Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.18 Dura Biotech Company Overview 83
5.18.1 Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
5.19 Edwards Lifesciences Corporation Company Overview 85
5.19.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.20 Emory University Company Overview 106
5.20.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 106
5.21 HighLife SAS Company Overview 108
5.21.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 108
5.22 HLT, Inc. Company Overview 109
5.22.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.23 Innovia LLC Company Overview 112
5.23.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 112
5.24 JenaValve Technology GmbH Company Overview 115
5.24.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 115
5.25 Leman Cardiovascular Company Overview 120
5.25.1 Leman Cardiovascular Pipeline Products & Ongoing Clinical Trials Overview 120
5.26 Mayo Clinic Company Overview 121
5.26.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 121
5.27 Medi-Line S.A. Company Overview 122
5.27.1 Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview 122
5.28 Medtronic plc Company Overview 123
5.28.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 123
5.29 Meril Life Sciences Pvt. Ltd. Company Overview 135
5.29.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 135
5.30 Micro Interventional Devices, Inc. Company Overview 136
5.30.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.31 MicroPort Scientific Corporation Company Overview 138
5.31.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 138
5.32 Mitralix Ltd. Company Overview 142
5.32.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.33 MitrAssist Ltd. Company Overview 143
5.33.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 143
5.34 Mitricares Company Overview 144
5.34.1 Mitricares Pipeline Products & Ongoing Clinical Trials Overview 144
5.35 NaviGate Cardiac Structures, Inc. Company Overview 145
5.35.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145
5.36 Neovasc Inc. Company Overview 146
5.36.1 Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview 146
5.37 Peca Labs, Inc. Company Overview 150
5.37.1 Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.38 PolyNova Cardiovascular LLC Company Overview 151
5.38.1 PolyNova Cardiovascular LLC Pipeline Products & Ongoing Clinical Trials Overview 151
5.39 RegenaGraft Company Overview 152
5.39.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 152
5.40 Revivicor, Inc. Company Overview 153
5.40.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.41 SAS Cormove Company Overview 154
5.41.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview 154
5.42 Scientific and Production Center Amphion, LLC Company Overview 155
5.42.1 Scientific and Production Center Amphion, LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.43 Sorin S.p.A. Company Overview 156
5.43.1 Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 156
5.44 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 160
5.44.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 160
5.45 St. Jude Medical, Inc. Company Overview 162
5.45.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
5.46 Stellenbosch University Company Overview 175
5.46.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 175
5.47 Strait Access Technologies (Pty) Ltd Company Overview 176
5.47.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 176
5.48 Symetis AG Company Overview 178
5.48.1 Symetis AG Pipeline Products & Ongoing Clinical Trials Overview 178
5.49 Tendyne Medical, Inc. Company Overview 184
5.49.1 Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.50 The Tel Aviv Sourasky Medical Center Company Overview 187
5.50.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 187
5.51 Thubrikar Aortic Valve, Inc. Company Overview 188
5.51.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 188
5.52 Tissue Regenix Ltd Company Overview 190
5.52.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 190
5.53 Transcatheter Technologies GmbH Company Overview 193
5.53.1 Transcatheter Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 193
5.54 Twelve, Inc Company Overview 196
5.54.1 Twelve, Inc Pipeline Products & Ongoing Clinical Trials Overview 196
5.55 UMC Utrecht Holding BV Company Overview 197
5.55.1 UMC Utrecht Holding BV Pipeline Products & Ongoing Clinical Trials Overview 197
5.56 University College London Company Overview 198
5.56.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 198
5.57 University of California, Irvine Company Overview 199
5.57.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 199
5.58 University of Pennsylvania Company Overview 202
5.58.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 202
5.59 Valtech Cardio Ltd. Company Overview 204
5.59.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 204
5.60 ValveXchange, Inc. Company Overview 205
5.60.1 ValveXchange, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.61 VueKlar Cardiovascular Ltd. Company Overview 208
5.61.1 VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 208
5.62 Xeltis AG Company Overview 210
5.62.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 210
6 Prosthetic Heart Valves- Recent Developments 211
7 Appendix 306
7.1 Methodology 306
7.2 About GlobalData 308
7.3 Contact Us 309
7.4 Disclaimer 309
【レポート販売概要】
■ タイトル：人工心臓弁の世界市場：パイプラインレビュー2015■ 英文：Prosthetic Heart Valves - Pipeline Review, 2015
■ 発行日：2015年4月28日
■ 調査会社：GlobalData
■ 商品コード：GDME0006EPD
■ 調査対象地域：グローバル
- 世界の核酸検査及びDNAシーケンシング市場2014This report provides:Estimates of facilities performing DNA sequencing and molecular diagnostic testing in France, Germany, Italy, Japan, Spain, UK and USA.Five-year test volume and sales forecasts by country. List of TablesTable 1. Laboratories Performing DNA Sequencing By Country Table 2. NAT Testing: Potential Laboratory Universe by Country Table 3. NAT Test Volume Forecasts b …
- 電動推進式人工衛星の世界市場ABSTRACTAbout Electric Propulsion Satellite Electric-powered satellite propulsion system employs electrical energy to change the velocity of spacecraft. Most all-electric satellite propulsion systems work by electrically expelling propellant or reaction mass at high speed. The hybrid propulsion systems engage both chemical and electrical propulsion technologies. Conventional electric thrusters use …
- 世界のパーソナルケア有効成分市場2015Global Personal Care Active Ingredients Industry Report 2015 is a professional and in-depth study on the current state of the Personal Care Active Ingredients industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Personal Care Active Ingredients market analysis is provided for the China markets includin …
- 砂糖市場：タイThis report is a comprehensive research of sugar industry in Thailand. The first two chapters of the report feature the country profile by giving general information on Thailand and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closing a …
- 下垂体ACTH過剰分泌(クッシング病)：グローバル臨床試験レビュー（2014年上半期）Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014" provides data on the Pituitary ACTH Hypersecretion (Cushing’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical t …
- 世界の香料（香水）製品市場動向：ニュース・イベント（2014年5月）Synopsis The report provides a review of the latest news and key events in the global fragrances market during May 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global fragrances market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global f …
- 複合現実感（MR）の世界市場予測The mixed reality technology refers to a system that combines the real and virtual world and is able to present them together on a single display. It is a multi-disciplinary field involving computer graphics, signal processing, mobile computing, user interfaces, information visualization, and the design of displays and sensors. The mixed reality systems are applied in a wide range of applications …
- 2014年戦略提言：アメリカの腫瘍マーカー検査市場Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450.HighlightsComprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Mortality statistics and scien …
- モバイルエッジコンピューティングの世界市場展望2017-20276According to Stratistics MRC, the Global Mobile Edge Computing Market is accounted for $200.37 million in 2017 and is expected to reach $2,772.36 million by 2026 growing at a CAGR of 33.9% during the forecast period. Some of the key factors boosting the market are raising demand for ultra-low latency and high bandwidth. However, lack of required infrastructure and deployment capabilities are hampe …
- 中東・アフリカの乳児用おむつ市場About Baby Diapers The increase in average disposable income is positively affecting the market. In many developing countries in MEA, the purchasing power of people has increased over the past few years. This has factored in the rising affordability of diapers. Additionally, with the rise in local vendors in the region, competition has increased, leading to price wars. This factor has led to a dec …
- SaaS型SCMソフトウェアの世界市場2015-2019About SaaS-based SCM SaaS-based SCM is a software installed in the cloud that facilitates the activities of an entire supply chain. This software provides accurate information and an end-to-end view of the supply chain process. The low installation cost of SaaS-based solutions enables enterprise software vendors to reach a large audience. This is true particularly for SMEs that generally have limi …
- 整形外科装置（医療機器）のグローバル市場This report provides a worldwide strategic overview of the orthopedics market, including forecasts for major geographic regions, market segments and product categories.In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globaliz …
- 自動車向け音声認識システム（VRシステム）の世界市場About the Global Automotive VR Systems The VR systems, which we know today, featuring advanced speech recognition, emerged in the automotive domain in 2004-2005. One of the first vehicles to release it was Honda Acura RL, wherein the system was a part of the standard equipment. Honda also offered the VR system in its Acura MDX and Odyssey models as optional equipment. The Honda VR system was based …
- ガラス包装の世界市場分析：用途別（食品・飲料、ビール、医薬品）、セグメント予測、-2020The global market for Glass Packaging is expected to reach USD 68.4 billion by 2020, according to a new study by Grand View Research, Inc. Growing beer consumption, especially in parts of Eastern Europe and Asia Pacific is expected to be a key driver for the growth of the market over the next five years. In addition, the increasing preference towards use of glass in packaging of food and beverage, …
- 高度圧力保護システム（HIPPS）の世界市場2017-2021About high-integrity pressure protection systemHIPPS is a type of safety instrumented system (SIS) that is used to safeguard a process to prevent a catastrophic release of flammable, toxic or explosive chemicals. Traditionally, in industrial plants, flare or relief systems are used for burning off flammables gases that are released through pressure relief valves during unplanned over-pressurizatio …
